Successfully utilising molecular imaging technologies in preclinical and clinical drug development can provide vital information which drug candidates are likely to be successful and reveal candidates that are likely to fail, enabling early decision making to reduce time and costs.

VIBevents’ Molecular Imaging in Drug Development conference, being held on 18 and 19 February 2009 in London, UK, will bring experts from the pharmaceutical and biotech industry together to discuss the latest developments in molecular imaging for preclinical and clinical drug development. Through a series of presentations, case studies and interactive discussions, participants learn new insight and gain hands-on experience in the latest trends and developments being used to drive and ensure success in this competitive environment.

Password: